Árangur á notkun líftæknigerðs espaðs storkuþáttar VIIa við meiriháttar blæðingum í opnum hjartaskurðaðgerðum

• Main Authors: Jóhann Páll Ingimarsson, Páll T. Önundarson, Felix Valsson, Brynjar Viðarsson, Tómas Guðbjartsson
• Format: Article in Journal/Newspaper
• Language: Icelandic
• Published: Læknafélag Íslands, Læknafélag Reykjavíkur 2008
• Subjects: Hjartasjúkdómar; Hjartaaðgerðir; Blæðingar (áverkar); Adult; Anticoagulants; Blood Loss; Surgical; Cardiac Surgical Procedures; Erythrocyte Transfusion; Factor VIIa; Hemostatic Techniques; Iceland; Postoperative Hemorrhage; Recombinant Proteins; Reoperation; Retrospective Studies; Treatment Outcome; Smella
• Online Access: http://hdl.handle.net/2336/41986

Neðst á síðunni er hægt að nálgast greinina í heild sinni með því að smella á hlekkinn View/Open INTRODUCTION: We evaluated the efficacy of activated recombinant factor VIIa (rFVIIa) administration for critical bleeding during cardiothoracic surgery in Iceland. MATERIALS AND METHODS: Over a 33 month...